|
PRLD Prelude Therapeutics Inc 1678660 |
| Balance Sheet |
|
Current Assets
|
$154,898,000.00 |
|
Assets
|
$189,363,000.00 |
|
Current Liabilities
|
$38,042,000.00 |
|
Liabilities
|
$55,630,000.00 |
|
Equity
|
$133,733,000.00 |
|
Shares Out
|
79803485.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-37,259,000.00 |
|
Investing Cash Flow
|
$-57,004,000.00 |
| Market Analysis |
Market Cap
|
$518,722,652.50 |
|
Price
|
$6.50 |
|
BVPS
|
1.68 |
|
PB
|
3.87 |
|
EPS
|
-0.14 |
|
PS
|
22.74 |
|
FCF
|
$-37,259,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:42 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:33 |
|
| Apr |
May |
Jun |
| 2026-03-10 |
-1.29 |
|
|
2026-05-12 |
-0.13 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-14 |
-0.41 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-0.26 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view PRLD documents filed with the SEC.
PRLD Filings
Clear
